Journal of Animal Science, Vol 74, Issue 1 218-225, Copyright © 1996 by American Society of Animal Science

CLINICAL TRIAL

Controlled, reversible suppression of estrous cycles in beef heifers and cows using agonists of gonadotropin-releasing hormone

M. J. D'Occhio, W. J. Aspden and T. R. Whyte
CSIRO Division of Tropical Animal Production, Tropical Beef Centre, Rockhampton, Queensland, Australia.

Agonists of GnRH were examined for their potential to achieve controlled, reversible suppression of estrous cycles in beef cattle. In Exp. 1, cyclic heifers received two (Group B2) or four (Group B4) buserelin (D-Ser[Bu(t)]6-Pro9-LHRH[1-9] nonapeptide ethylamide) implants and degree of cessation of estrous cycles was monitored. Treatment with buserelin caused estrous cycles to cease, as indicated by basal (.2 ng/mL) concentrations of progesterone, for 48.4 +/- 3.8 d (mean +/- SEM) in Group B2, which was less (P = .6) than the 87.4 +/- 17.4 d in Group B4. In Exp. 2, heifers treated with one (Group D1) or two (Group D2) implants of deslorelin (D-Trp6-Pro9-des-Gly10-LHRH ethylamide) had basal progesterone concentrations for 203 +/- 26 d (Group D1) and 170 +/- 28 d (Group D2; P > .05). In Exp. 3, stage of the estrous cycle was synchronized in cows, and, on d 7 of the ensuing cycle, cows received four deslorelin implants for 28 (Group D28) or 56 d (Group D56). Treatment with deslorelin induced an acute increase in plasma concentrations of immunoactive and bioactive LH, which remained increased over 7 d of observation. Based on profiles of progesterone, cows did not develop a functional corpus luteum during deslorelin treatment. Days to first and second estrus after implant removal were similar for cows in Group D28 (23.6 +/- 2.1 and 40.2 +/- 4.2 d, respectively) and Group D56 (21.5 +/- 3.3 and 44.3 +/- 2.9 d). The findings indicated that GnRH agonists block estrous cycles in cattle. Also, estrous cycles returned after discontinuation of treatment. Furthermore, the consistent and predictable responses detected in cows after implant removal indicated that agonists should be suitable for achieving a controlled, reversible suppression of estrous cycles in cattle.

This article has been cited by other articles:

				L. Delbecchi and P. Lacasse Short Communication: Suppression of Estrous Cycles in Lactating Cows Has No Effect on Milk Production J Dairy Sci, February 1, 2006; 89(2): 636 - 639. [Abstract] [Full Text] [PDF]

				D. L. Baker, M. A. Wild, M. D. Hussain, R. L. Dunn, and T. M. Nett EVALUATION OF REMOTELY DELIVERED LEUPROLIDE ACETATE AS A CONTRACEPTIVE AGENT IN FEMALE ELK (CERVUS ELAPHUS NELSONI) J. Wildl. Dis., October 1, 2005; 41(4): 758 - 767. [Abstract] [Full Text] [PDF]

				C A Herbert, T E Trigg, M B Renfree, G Shaw, D C Eckery, and D W Cooper Long-term effects of deslorelin implants on reproduction in the female tammar wallaby (Macropus eugenii) Reproduction, March 1, 2005; 129(3): 361 - 369. [Abstract] [Full Text] [PDF]

				D. L. Baker, M. A. Wild, M. M. Connor, H. B. Ravivarapu, R. L. Dunn, and T. M. Nett GONADOTROPIN-RELEASING HORMONE AGONIST: A NEW APPROACH TO REVERSIBLE CONTRACEPTION IN FEMALE DEER J. Wildl. Dis., October 1, 2004; 40(4): 713 - 724. [Abstract] [Full Text] [PDF]

				C A Herbert, T E Trigg, and D W Cooper Effect of deslorelin implants on follicular development, parturition and post-partum oestrus in the tammar wallaby (Macropus eugenii) Reproduction, February 1, 2004; 127(2): 265 - 273. [Abstract] [Full Text] [PDF]

				T.L. Davis, M.L. Mussard, H. Jimenez-Severiano, W.J. Enright, and J.E. Kinder Chronic Treatment with an Agonist of Gonadotropin-Releasing Hormone Enhances Luteal Function in Cattle Biol Reprod, August 1, 2003; 69(2): 398 - 403. [Abstract] [Full Text] [PDF]

				R. P. Wettemann, C. A. Lents, N. H. Ciccioli, F. J. White, and I. Rubio Nutritional- and suckling-mediated anovulation in beef cows J Anim Sci, February 1, 2003; 81(14_suppl_2): E48 - 59. [Abstract] [Full Text] [PDF]